NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Stefano Stabile
Ospedale Niguarda Ca' Granda, Milan - / Italy
Others
AD Scientific Index ID: 5518341
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Stefano Stabile's MOST POPULAR ARTICLES
1-)
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectivesG Patelli, A Zeppellini, F Spina, E Righetti, S Stabile, A Amatu, F Tosi, ...Cancer Treatment Reviews 104, 102351, 2022422022
2-)
A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancerSR Volovat, TE Ciuleanu, P Koralewski, JEG Olson, A Croitoru, K Koynov, ...Oncotarget 11 (33), 3105, 2020182020
3-)
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label …S Pignata, G Scambia, C Schettino, L Arenare, C Pisano, D Lombardi, ...The Lancet Oncology 24 (3), 286-296, 2023172023
4-)
Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?C Cagnazzo, MG Besse, D Manfellotto, P Minghetti, S Cazzaniga, ...Tumori Journal 107 (1), 6-11, 2021172021
5-)
Pooled analysis of clinical outcome of patients with chemorefractory metastatic colorectal cancer treated within phase I/II clinical studies based on individual biomarkers of …A Sartore-Bianchi, A Amatu, E Bonazzina, S Stabile, L Giannetta, G Cerea, ...Targeted oncology 12, 525-533, 2017162017
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept